54767-75-8

Vasodilator (peripheral).

ChEBI: (1S,2R)-2-(octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol is an alkylbenzene.

Bemperil;Cerebro;Circleton;Cp 556s;Dulasi;Duloctil;Euvasal;Farectil;Fluversin;Fluvisco;Hemoantin;Iangene;Ibisul;Loctidon;Metactiv;Octamet;Polivasal;Sudil;Sulc;Sulodene;Suloktil;Sutidil;Tamid;Vascudil.

Suloctidil, a peripheral vasodilator, was introduced in 1975 for the treatment of arterial disease. By 1985 its use had been associated with serious adverse effects, including deaths from hepatitis. In July 1985 renewal for approval was refused in the Federal Republic of Germany. This was followed by the voluntary withdrawal of the drug by the manufacturer firstly in several European countries and ultimately on a worldwide basis.